Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.
Clinical trial NCT03218683 · TERMINATED
Trial details
- NCT number
- NCT03218683
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2021-10-08
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.